4K9.F - CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp.

2080 - 777 Hornby Street
Vancouver, BC V6Z 1S4
Canada
214 704 7942
https://www.canafarmacorp.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Phil Klauder	Acting Chief Financial Officer	12.25k	N/A	N/A
Mr. Tyrone Ross Jr.	VP of Communications	N/A	N/A	N/A
Mr. Vitaly Fargesen	Sr. VP of Strategic Planning	N/A	N/A	N/A
Mr. Igor Palatnik	Sr. VP of Product Acquisition	N/A	N/A	N/A
Mr. Daniel Kail	Sr. VP of Product Acquisition	N/A	N/A	N/A
Mr. Edward James Kirkham	Chief Grower	N/A	N/A	1974
Mr. Djibril Gibson Kagni	Head of Media Management	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.

Corporate Governance

CanaFarma Hemp Products Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.